Delphinus Medical Technologies develops, commercializes, sells, and services the breast cancer screening solutions to hospitals and imaging clinics in the United States and internationally. It commercializes SoftVue, a three-dimensional and tomographic ultrasound imaging and risk assessment device that examines women's breasts for the presenceof benign and/or malignant masses, assesses breast cancer risks, diagnoses breast diseases, and monitors therapy. The company was founded in 2009 and is based in Detroit, Michigan.

Biotechnology

Health Care

Delphinus Medical Technologies, Inc.

Mark J Forchette

Thomas Boese

Scott White

Peter Littrup

Heather Rone

Dane Baruzzini

Engineering Team

Operations and Engineering Team

Leadership Team

Engineering and Clinical Services

Sales Team

Delphinus Medical Technologies, Inc.

Org chart

Teams

Engineering Team

Operations and Engineering Team

Leadership Team

Engineering and Clinical Services

Sales Team

Similar companies